1. Home
  2. GTEC vs NVNO Comparison

GTEC vs NVNO Comparison

Compare GTEC & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenland Technologies Holding Corporation

GTEC

Greenland Technologies Holding Corporation

HOLD

Current Price

$1.06

Market Cap

17.7M

Sector

Industrials

ML Signal

HOLD

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$0.34

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTEC
NVNO
Founded
2006
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
7.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GTEC
NVNO
Price
$1.06
$0.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
463.9K
417.4K
Earning Date
11-07-2025
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.92
N/A
Revenue
$86,168,664.00
N/A
Revenue This Year
$5.64
N/A
Revenue Next Year
$3.93
N/A
P/E Ratio
$0.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.58
$0.30
52 Week High
$2.92
$5.62

Technical Indicators

Market Signals
Indicator
GTEC
NVNO
Relative Strength Index (RSI) 58.42 45.03
Support Level $0.58 $0.35
Resistance Level $1.15 $0.39
Average True Range (ATR) 0.10 0.03
MACD 0.02 0.01
Stochastic Oscillator 80.73 55.35

Price Performance

Historical Comparison
GTEC
NVNO

About GTEC Greenland Technologies Holding Corporation

Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: